Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News CSL Limited’s AEGIS-II trial of CSL112 fails to meet primary endpoint in heart attack patients CSL Limited (ASX:CSL; USOTC:CSLLY), a renowned global biotechnology leader, disclosed the top-line outcomes from its eagerly anticipated Phase… byPallavi MadhirajuFebruary 12, 2024